Delivery Order SPE2DX22D0010-SPE2D825FJA93
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award on July 14, 2025, for the supply of Dextroamphetamine SR Caps 15mg valued at $7,071.17. This non-set-aside, competitively awarded contract is funded by the Defense Logistics Agency's Medical Supply Chain and will be completed by July 15, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dextroamphetamine SR Caps 15mg, a controlled-release central nervous system stimulant medication. This firm fixed-price delivery order, valued at $6,915.33, represents a competitive award with no set-aside designation and is scheduled for completion by August 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,073.53 delivery order to AmerisourceBergen Drug Corp for 100 units of dextroamphetamine extended-release 30mg tablets. The contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and utilized firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules in a quantity of 100 units, with a ceiling value of $2,008.80. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 4, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a contract ceiling value of $11,475.72. This firm fixed-price delivery order, which is due for completion by August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dextroamphetamine ER 15 mg capsules (90-count units) with a ceiling value of $4,078.51. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,127.41 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $1,905.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dextroamphetamine ER 10 mg capsules (100 count). The award was competitively procured with no set-aside designation and requires ultimate completion by July 15, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJA93Delivery Order
The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dextroamphetamine SR Caps 15MG, a controlled pharmaceutical product used in treating attention deficit disorders. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $9,714.59 and is scheduled for completion by September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under a larger vehicle supporting the department's pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally. The company demonstrates substantial capability in federal medical procurement through its extensive portfolio of competitive contract awards covering diverse therapeutic domains, positioning it as a critical vendor for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/2/25 |